JP2018501069A - 褐色脂肪組織を活性化する際に神経を阻害するための方法及び装置 - Google Patents
褐色脂肪組織を活性化する際に神経を阻害するための方法及び装置 Download PDFInfo
- Publication number
- JP2018501069A JP2018501069A JP2017553044A JP2017553044A JP2018501069A JP 2018501069 A JP2018501069 A JP 2018501069A JP 2017553044 A JP2017553044 A JP 2017553044A JP 2017553044 A JP2017553044 A JP 2017553044A JP 2018501069 A JP2018501069 A JP 2018501069A
- Authority
- JP
- Japan
- Prior art keywords
- bat
- electrical signal
- nerve
- patient
- nerves
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0472—Structure-related aspects
- A61N1/0492—Patch electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/3603—Control systems
- A61N1/36034—Control systems specified by the stimulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/36167—Timing, e.g. stimulation onset
- A61N1/36171—Frequency
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0622—Optical stimulation for exciting neural tissue
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Pathology (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Electrotherapy Devices (AREA)
- Radiation-Therapy Devices (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Laser Surgery Devices (AREA)
Abstract
Description
(1) 第1の神経調節因子を褐色脂肪組織(BAT)の蓄積部位(depot)に適用することであって、前記第1の神経調節因子の前記適用が前記BAT内の第1の神経タイプの活性化を引き起こすことで前記BATのエネルギー消費を増加させる、ことと、
前記第1の神経調節因子の前記適用と同時に前記BATの蓄積部位に第2の神経調節因子を適用することであって、前記第2の神経調節因子の前記適用が前記第1の神経タイプと異なる前記BAT内の第2の神経タイプを阻害する、ことと、を含む、医療方法。
(2) 前記第1の神経タイプが交感神経を含み、前記第2の神経タイプが副交感神経を含む、実施態様1に記載の方法。
(3) 前記第1の神経タイプが交感神経を含み、前記第2の神経タイプが知覚神経を含む、実施態様1に記載の方法。
(4) 前記第2の神経調節因子の前記適用が、前記第1の神経調節因子の前記適用が開始されるよりも前に開始されることで前記第1の神経タイプが活性化されるよりも前に前記第2の神経タイプの阻害が開始される、実施態様1に記載の方法。
(5) 前記第1の神経調節因子を適用することが、前記BATの蓄積部位に第1の電気信号を印加することを含み、前記第2の神経調節因子を適用することが、前記BATの蓄積部位に前記第1の電気信号とは異なる第2の電気信号を印加することを含む、実施態様1に記載の方法。
(7) 前記第1の神経調節因子を適用することが、前記BATの蓄積部位に第1の化学物質を送達することを含み、前記第2の神経調節因子を適用することが、前記BATの蓄積部位に前記第1の化学物質とは異なる第2の化学物質を送達することを含む、実施態様1に記載の方法。
(8) 前記第1の神経調節因子を適用することが、前記BATの蓄積部位に電気信号を印加すること、前記BATの蓄積部位に化学物質を送達すること、前記BATの蓄積部位を冷却すること、及び前記BATの蓄積部位に光を照射することのうちの少なくとも1つを含み、前記第2の神経調節因子を適用することが、前記BATの蓄積部位に異なる電気信号を印加すること、及び前記BATの蓄積部位に異なる化学物質を送達することのうちの少なくとも一方を含む、実施態様1に記載の方法。
(9) 患者の褐色脂肪組織(BAT)の蓄積部位に近接する患者の交感神経系を神経調節することで前記BATを活性化して前記BATのエネルギー消費を増加させることと、
前記交感神経系を前記神経調節することと同時に、前記褐色脂肪組織の蓄積部位に近接する前記患者の副交感神経系を抑制することと、を含む、医療方法。
(10) 前記交感神経系を神経調節することが、前記BATを神経支配している交感神経を活性化し、前記副交感神経系を抑制することが、前記BATを神経支配している副交感神経を抑制し、前記副交感神経の各々が前記交感神経の各々よりも大きい径を有する、実施態様9に記載の方法。
(12) 前記交感神経系を神経調節することが、前記患者に第1の電気信号を印加することを含む、実施態様9に記載の方法。
(13) 前記副交感神経系を抑制することが、前記患者に前記第1の電気信号とは異なる第2の電気信号を印加することを含む、実施態様11に記載の方法。
(14) 前記第1の電気信号の電流が、前記第2の電気信号の電流よりも10〜100倍大きい範囲にある、実施態様13に記載の方法。
(15) 前記第2の電気信号が、前記第1の電気信号と比較してより低エネルギーの過分極パルス、及び前記第1の電気信号と比較してより低エネルギーの脱分極パルスのうちの一方を含む、実施態様13に記載の方法。
(17) 前記交感神経系を神経調節することが、前記患者に第1の化学物質を投与することを含む、実施態様9に記載の方法。
(18) 前記副交感神経系を抑制することが、前記患者に前記第1の化学物質とは異なる第2の化学物質を投与すること、及び前記患者に電気信号を印加することのうちの一方を含む、実施態様17に記載の方法。
(19) 前記交感神経系を神経調節することが、前記患者に電気信号を印加すること、前記患者に化学物質を投与すること、前記患者を冷却すること、及び前記患者に光を照射することのうちの少なくとも1つを含む、実施態様9に記載の方法。
(20) 褐色脂肪組織(BAT)の蓄積部位に近接する患者の組織に直接接触するように、かつ前記患者に第1及び第2の電気信号を同時に供給するように構成された少なくとも1つの電極であって、前記第1の電気信号が前記BAT内の第1の神経タイプの活性化を引き起こすことで前記BATのエネルギー消費を増加させるように構成され、前記第2の電気信号が前記第1の神経タイプとは異なる前記BAT内の第2の神経タイプを阻害するように構成されている、少なくとも1つの電極と、
前記少なくとも1つの電極と電子通信しており、かつ前記少なくとも1つの電極により供給される前記第1及び第2の電気信号を発生するように構成された少なくとも1つの信号生成器と、を備える、医療器具。
Claims (1)
- 褐色脂肪組織(BAT)の蓄積部位に近接する患者の組織に直接接触するように、かつ前記患者に第1及び第2の電気信号を同時に供給するように構成された少なくとも1つの電極であって、前記第1の電気信号が前記BAT内の第1の神経タイプの活性化を引き起こすことで前記BATのエネルギー消費を増加させるように構成され、前記第2の電気信号が前記第1の神経タイプとは異なる前記BAT内の第2の神経タイプを阻害するように構成されている、少なくとも1つの電極と、
前記少なくとも1つの電極と電子通信しており、かつ前記少なくとも1つの電極により供給される前記第1及び第2の電気信号を発生するように構成された少なくとも1つの信号生成器と、を備える、医療器具。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/584,046 US10092738B2 (en) | 2014-12-29 | 2014-12-29 | Methods and devices for inhibiting nerves when activating brown adipose tissue |
US14/584,046 | 2014-12-29 | ||
PCT/US2015/065513 WO2016109169A1 (en) | 2014-12-29 | 2015-12-14 | Methods and devices for inhibiting nerves when activating brown adipose tissue |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018501069A true JP2018501069A (ja) | 2018-01-18 |
JP6668379B2 JP6668379B2 (ja) | 2020-03-18 |
Family
ID=55236897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017553044A Active JP6668379B2 (ja) | 2014-12-29 | 2015-12-14 | 褐色脂肪組織を活性化する際に神経を阻害するための方法及び装置 |
Country Status (6)
Country | Link |
---|---|
US (3) | US10092738B2 (ja) |
EP (1) | EP3240606B1 (ja) |
JP (1) | JP6668379B2 (ja) |
CN (1) | CN107278161B (ja) |
BR (1) | BR112017013892B1 (ja) |
WO (1) | WO2016109169A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2021516098A (ja) * | 2018-03-09 | 2021-07-01 | ゼネラル・エレクトリック・カンパニイ | ニューロモジュレーション技術 |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9044606B2 (en) | 2010-01-22 | 2015-06-02 | Ethicon Endo-Surgery, Inc. | Methods and devices for activating brown adipose tissue using electrical energy |
US10092738B2 (en) | 2014-12-29 | 2018-10-09 | Ethicon Llc | Methods and devices for inhibiting nerves when activating brown adipose tissue |
US11324673B2 (en) | 2016-11-18 | 2022-05-10 | Miraki Innovation Think Tank Llc | Cosmetic appearance of skin |
JP2020503111A (ja) * | 2016-12-27 | 2020-01-30 | アヴェント インコーポレイテッド | 糖尿病性末梢神経障害を処置するための物品及び方法 |
AU2018226785A1 (en) * | 2017-03-01 | 2019-10-24 | Miraki Innovation Think Tank Llc | Cryotherapies |
EP3606482A4 (en) | 2017-04-05 | 2021-01-06 | Miraki Innovation Think Tank LLC | CREATION OF COLD SLUDGE AT THE DELIVERY LOCATION |
JP7085762B2 (ja) | 2017-04-05 | 2022-06-17 | ミラキ イノベーション シンク タンク エルエルシー | 低温スラリ閉じ込め |
US10500342B2 (en) | 2017-08-21 | 2019-12-10 | Miraki Innovation Think Tank Llc | Cold slurry syringe |
WO2019212972A1 (en) * | 2018-04-29 | 2019-11-07 | Gandel Brian A | Device and method for inducing lypolysis in humans |
EP4271295A1 (en) | 2021-09-29 | 2023-11-08 | Cilag GmbH International | Surgical devices, systems, and methods for control of one visualization with another |
US20230100698A1 (en) * | 2021-09-29 | 2023-03-30 | Cilag Gmbh International | Methods for Controlling Cooperative Surgical Instruments |
WO2023052941A1 (en) | 2021-09-29 | 2023-04-06 | Cilag Gmbh International | Surgical system for delivering energy to tissue in an anatomic space and monitoring a tissue parameter in a different anatomic space |
WO2023052943A1 (en) | 2021-09-29 | 2023-04-06 | Cilag Gmbh International | Surgical devices, systems, and methods for control of one visualization with another |
WO2023052935A1 (en) | 2021-09-29 | 2023-04-06 | Cilag Gmbh International | Surgical devices, systems, and methods for control of one visualization with another |
EP4221613A1 (en) | 2021-09-29 | 2023-08-09 | Cilag GmbH International | Surgical system for altering the body's sensing of food |
WO2023052947A1 (en) | 2021-09-29 | 2023-04-06 | Cilag Gmbh International | Surgical devices, systems, and methods for control of one visualization with another |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030018367A1 (en) * | 2001-07-23 | 2003-01-23 | Dilorenzo Daniel John | Method and apparatus for neuromodulation and phsyiologic modulation for the treatment of metabolic and neuropsychiatric disease |
JP2011505981A (ja) * | 2007-12-14 | 2011-03-03 | エシコン・インコーポレイテッド | デルマトーム刺激の装置及び方法 |
US20120290023A1 (en) * | 2011-05-09 | 2012-11-15 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Method, device and system for modulating an activity of brown adipose tissue in a vertebrate subject |
JP2013517835A (ja) * | 2010-01-22 | 2013-05-20 | エシコン・エンド−サージェリィ・インコーポレイテッド | 電気エネルギーを用いて褐色脂肪組織を活性化する方法および装置 |
JP2013126486A (ja) * | 2011-12-19 | 2013-06-27 | Panasonic Corp | 電気刺激装置 |
US20140088487A1 (en) * | 2010-12-29 | 2014-03-27 | Ethicon Endo-Surgery, Inc. | Methods and devices for activating brown adipose tissue with light |
Family Cites Families (207)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4596792A (en) | 1981-09-04 | 1986-06-24 | The Regents Of The University Of California | Safe vaccine for hepatitis containing polymerized serum albumin |
US4498843A (en) | 1982-08-02 | 1985-02-12 | Schneider Philip H | Insulin infusion pump |
JPS5938877A (ja) | 1982-08-30 | 1984-03-02 | Musashi Eng Kk | 紙葉判別方法 |
US4599230A (en) | 1984-03-09 | 1986-07-08 | Scripps Clinic And Research Foundation | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
US4599231A (en) | 1984-03-09 | 1986-07-08 | Scripps Clinic And Research Foundation | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
US4608251A (en) | 1984-11-09 | 1986-08-26 | Pitman-Moore, Inc. | LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues |
US4601903A (en) | 1985-05-01 | 1986-07-22 | The United States Of America As Represented By The Department Of Health And Human Services | Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease |
GB8519154D0 (en) | 1985-07-30 | 1985-09-04 | Ici Plc | Aromatic ethers |
GB8607312D0 (en) | 1986-03-25 | 1986-04-30 | Ici Plc | Therapeutic agents |
GB8714901D0 (en) | 1986-07-23 | 1987-07-29 | Ici Plc | Amide derivatives |
US4978338A (en) | 1988-04-21 | 1990-12-18 | Therex Corp. | Implantable infusion apparatus |
CH676164A5 (ja) | 1988-05-28 | 1990-12-14 | Sc Techn Dipl Ing Peter A Neuk | |
CN2045308U (zh) | 1988-10-12 | 1989-10-04 | 路雪清 | 电子减肥机 |
CN2045380U (zh) | 1989-01-07 | 1989-10-04 | 苏州市制冷设备厂 | 氯气液化装置 |
DK339289D0 (da) | 1989-07-07 | 1989-07-07 | Dak Lab As | Farmaceutisk praeparat |
US5811094A (en) | 1990-11-16 | 1998-09-22 | Osiris Therapeutics, Inc. | Connective tissue regeneration using human mesenchymal stem cell preparations |
US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US5837539A (en) | 1990-11-16 | 1998-11-17 | Osiris Therapeutics, Inc. | Monoclonal antibodies for human mesenchymal stem cells |
GB9111426D0 (en) | 1991-05-28 | 1991-07-17 | Ici Plc | Chemical compounds |
US5453270A (en) | 1992-03-30 | 1995-09-26 | Hypermetabolic Therapies, Inc. | Pharmaceutical composition and method for hypermetabolic weight loss |
GB9209076D0 (en) | 1992-04-27 | 1992-06-10 | Ici Plc | Chemical compounds |
AU4543193A (en) | 1992-06-22 | 1994-01-24 | Henry E. Young | Scar inhibitory factor and use thereof |
WO1995006411A1 (en) | 1993-08-30 | 1995-03-09 | Lipocyte, Inc. | Method and composition for weight reduction |
US6015686A (en) | 1993-09-15 | 2000-01-18 | Chiron Viagene, Inc. | Eukaryotic layered vector initiation systems |
US5736396A (en) | 1995-01-24 | 1998-04-07 | Case Western Reserve University | Lineage-directed induction of human mesenchymal stem cell differentiation |
US5731408A (en) | 1995-04-10 | 1998-03-24 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Peptides having potent antagonist and agonist bioactivities at melanocortin receptors |
US5837670A (en) | 1995-04-18 | 1998-11-17 | Hartshorn; Richard Timothy | Detergent compositions having suds suppressing properties |
FR2733513B1 (fr) | 1995-04-25 | 1997-07-18 | Centre Nat Rech Scient | Lignees immortalisees de cellules issues du tissu adipeux humain, leur procede de preparation et leurs applications |
US5789654A (en) | 1996-05-09 | 1998-08-04 | Beth Israel Hospital Association | Transgenic animals deficient in endogenous β3 -adrenergic receptor and uses thereof |
US6246912B1 (en) | 1996-06-27 | 2001-06-12 | Sherwood Services Ag | Modulated high frequency tissue modification |
US5827740A (en) | 1996-07-30 | 1998-10-27 | Osiris Therapeutics, Inc. | Adipogenic differentiation of human mesenchymal stem cells |
IT1286236B1 (it) | 1996-09-24 | 1998-07-08 | Galaxy Top International Spa | Procedimento per la stimolazione controllata di regioni predefinite del corpo umano tramite l'applicazione di segnali elettrici variabili |
US6224873B1 (en) | 1996-09-30 | 2001-05-01 | Zhishin, Llc | Regulation of appetite, body weight and athletic function with materials derived from citrus varieties |
ES2339908T3 (es) | 1996-09-30 | 2010-05-26 | Dennis Jones | Regulacion del peso corporal con materiales derivados de variedades del genero de citricos. |
AU2809797A (en) | 1997-01-15 | 1998-08-07 | Centre National De La Recherche Scientifique Centre De Recherche Sur L'endocrinologie Moleculaire Et Le Developpement | Respiration uncoupling protein |
WO1998045313A1 (en) | 1997-04-04 | 1998-10-15 | Amylin Pharmaceuticals, Inc. | Novel uncoupling protein and methods of use |
EP0980433A1 (en) | 1997-05-07 | 2000-02-23 | Novartis-Erfindungen Verwaltungsgesellschaft m.b.H. | Uncoupling protein homologue: ucp 3 |
US6426411B1 (en) | 1997-05-30 | 2002-07-30 | Dana-Farber Cancer Institute | PGC-1, a novel brown fat pparγ coactivator |
US5911992A (en) | 1997-06-12 | 1999-06-15 | A. Glenn Braswell | Method for controlling weight with hypericum perforatum and garcinia cambogia |
SE9702457D0 (sv) | 1997-06-26 | 1997-06-26 | Pharmacia & Upjohn Ab | Screening |
US6072100A (en) | 1998-01-28 | 2000-06-06 | Johnson & Johnson Consumer Products, Inc. | Extrudable compositions for topical or transdermal drug delivery |
ES2335826T3 (es) | 1998-02-05 | 2010-04-05 | Miwa Science Laboratory Inc. | Aparato de irradiacion de ondas ultrasonicas y procedimiento de tratamiento no terapeutico. |
DE19815411A1 (de) | 1998-04-06 | 1999-10-07 | Solvay Pharm Gmbh | Thermogenese stimulierend wirksame Arzneimittel |
WO2000004037A1 (en) | 1998-07-14 | 2000-01-27 | Amylin Pharmaceuticals, Inc. | Uncoupling protein 4 (ucp-4) and methods of use |
ATE280615T1 (de) | 1998-08-31 | 2004-11-15 | Johnson & Johnson Consumer | Elektrotransportvorrichtung mit klingen |
US6605297B2 (en) | 1998-09-01 | 2003-08-12 | Janiftec, Inc. | Substances having antiobese and visceral fat-reducing functions and utilization thereof |
US6532286B1 (en) | 1998-12-23 | 2003-03-11 | At&T Corp. | Method and system for processing a telephone call |
FR2788438B1 (fr) | 1999-01-14 | 2003-10-03 | Arkopharma Laboratoires | Composition pour le traitement de l'obesite et procede de traitement esthetique |
US6197580B1 (en) | 1999-02-01 | 2001-03-06 | American Home Products Corporation | Transcriptional regulation of the human β3-adrenergic receptor gene |
EP1172113A4 (en) | 1999-04-16 | 2004-06-30 | Sumitomo Pharma | MEDICINE FOR AUTONOMOUS NEUROPATHIES |
JP3207823B2 (ja) | 1999-04-28 | 2001-09-10 | リノール油脂株式会社 | 共役リノール酸を有効成分とする褐色脂肪増加剤 |
US7060437B1 (en) | 1999-05-05 | 2006-06-13 | Ohio University | Growth hormone-regulatable brown adipose tissue genes and proteins and uses thereof |
JP4155669B2 (ja) | 1999-06-14 | 2008-09-24 | 独立行政法人科学技術振興機構 | 植物の発熱関連遺伝子と発熱関連タンパク質 |
US6548739B2 (en) | 1999-06-18 | 2003-04-15 | City Of Hope | Method for activating peroxisome proliferator activated receptor-γ |
US6607500B2 (en) | 1999-07-08 | 2003-08-19 | Cyclotec Advanced Medical Technologies, Inc. | Integrated cast and muscle stimulation system |
US6445955B1 (en) | 1999-07-08 | 2002-09-03 | Stephen A. Michelson | Miniature wireless transcutaneous electrical neuro or muscular-stimulation unit |
US6381496B1 (en) | 1999-10-01 | 2002-04-30 | Advanced Bionics Corporation | Parameter context switching for an implanted device |
US6207878B1 (en) | 1999-10-21 | 2001-03-27 | University Of Iowa Research Foundation | Sarcospan-deficient mouse as a model for clinical disorders associated with sarcospan mutations |
US6983753B1 (en) | 1999-11-17 | 2006-01-10 | Smithkline Beecham Corporation | Infrared thermography |
JP4723707B2 (ja) | 1999-12-22 | 2011-07-13 | パナソニック電工株式会社 | 痩身器具 |
GB0002059D0 (en) | 2000-01-28 | 2000-03-22 | Melacure Therapeutics Ab | Novel aromatic amines |
JP2001259047A (ja) | 2000-03-22 | 2001-09-25 | Matsushita Seiko Co Ltd | 体脂肪燃焼方法 |
AU2001249296B2 (en) | 2000-03-23 | 2005-03-24 | Merck Sharp & Dohme Corp. | Substituted piperidines as melanocortin receptor agonists |
US6472398B1 (en) | 2000-03-23 | 2002-10-29 | Merck & Co., Inc. | Spiropiperidine derivatives as melanocortin receptor agonists |
US6475530B1 (en) | 2000-05-31 | 2002-11-05 | Eric H. Kuhrts | Methods and compositions for producing weight loss |
AU2001283199A1 (en) | 2000-08-08 | 2002-02-18 | Millennium Pharmaceuticals, Inc. | Methods and compositions for the diagnosis and treatment of brown adipose cell disorders |
US6767915B2 (en) | 2000-08-23 | 2004-07-27 | Merck & Co., Inc. | Substituted piperidines as melanocortin receptor agonists |
DZ3415A1 (fr) | 2000-08-31 | 2002-03-07 | Chiron Corp | Guanidinobenzamides comme mc4-r agonistes. |
US6895279B2 (en) | 2000-09-15 | 2005-05-17 | Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California | Method and apparatus to treat disorders of gastrointestinal peristalsis |
US6922590B1 (en) | 2000-11-21 | 2005-07-26 | Advanced Bionics Corporation | Systems and methods for treatment of diabetes by electrical brain stimulation and/or drug infusion |
US7440806B1 (en) | 2000-11-21 | 2008-10-21 | Boston Scientific Neuromodulation Corp. | Systems and methods for treatment of diabetes by electrical brain stimulation and/or drug infusion |
AU2002240007B2 (en) | 2001-01-22 | 2007-02-15 | Curagen Corporation | BFIT (brown fat inducible thioesterase) polypeptides and polynucleotides and their use |
WO2002059095A1 (en) | 2001-01-23 | 2002-08-01 | Eli Lilly And Company | Melanocortin receptor agonists |
WO2002059107A1 (en) | 2001-01-23 | 2002-08-01 | Eli Lilly And Company | Substituted piperidines/piperazines as melanocortin receptor agonists |
DE60205727T2 (de) | 2001-01-23 | 2006-06-29 | Eli Lilly And Co., Indianapolis | Piperazin- und piperidinderivate als agonisten des melanocortin-rezeptors |
ATE341327T1 (de) | 2001-02-28 | 2006-10-15 | Merck & Co Inc | Acylierte piperidin-derivate als melanocortin-4- rezeptor-agonisten |
AU2002250343B2 (en) | 2001-02-28 | 2006-05-25 | Merck Sharp & Dohme Corp. | Acylated piperidine derivatives as melanocortin-4 receptor agonists |
GEP20053710B (en) | 2001-02-28 | 2005-12-26 | Merck & Co Inc | Acylated Piperidine Derivatives as Melanocortin-4 Receptor Agonists |
EP1767525A1 (en) | 2001-04-09 | 2007-03-28 | Novartis Vaccines and Diagnostics, Inc. | Guanidino compounds as melanocortin-4 receptor (MC4-R) agonists |
US6911447B2 (en) | 2001-04-25 | 2005-06-28 | The Procter & Gamble Company | Melanocortin receptor ligands |
JP2004533297A (ja) | 2001-05-29 | 2004-11-04 | メドトロニック・インコーポレーテッド | 心臓病の予防及び処置のための閉ループ神経調節システム |
ATE480620T1 (de) | 2001-07-05 | 2010-09-15 | Dana Farber Cancer Inst Inc | Neue pgc-1-isoformen und deren verwendungen |
CA2453515A1 (en) | 2001-07-11 | 2003-01-23 | Palatin Technologies, Inc. | Linear and cyclic melanocortin receptor-specific peptides |
DE60234348D1 (de) | 2001-07-17 | 2009-12-24 | Teijin Ltd | Selektionsverfahren für eine durch das austesten einer ppard aktivierenden wirkung charakterisierten substanz und arzneistoff |
EP1411940B1 (en) | 2001-07-18 | 2008-10-15 | Merck & Co., Inc. | Bridged piperidine derivatives as melanocortin receptor agonists |
US20070162085A1 (en) | 2001-07-23 | 2007-07-12 | Dilorenzo Biomedical, Llc | Method, apparatus, surgical technique, and stimulation parameters for autonomic neuromodulation for the treatment of obesity |
US20090118780A1 (en) | 2001-07-23 | 2009-05-07 | Dilorenzo Daniel John | Method and apparatus for conformal electrodes for autonomic neuromodulation for the treatment of obesity and other conditions |
US6977264B2 (en) | 2001-07-25 | 2005-12-20 | Amgen Inc. | Substituted piperidines and methods of use |
US7115607B2 (en) | 2001-07-25 | 2006-10-03 | Amgen Inc. | Substituted piperazinyl amides and methods of use |
BR0211566A (pt) | 2001-08-08 | 2004-11-30 | Kevin R Orton | Aparelho e método para redução de peso eletricamente condutor |
AU2002331898A1 (en) | 2001-09-24 | 2003-04-07 | Board Of Supervisors Of Louisiana State Universityand Agricultural And Mechanical College | Induction of brown adipocytes by transcription factor nfe2l2 |
US20030082168A1 (en) | 2001-10-22 | 2003-05-01 | Inna Yegorova | Compositions and methods for facilitating weight loss |
JP4518378B2 (ja) | 2001-10-29 | 2010-08-04 | ベーリンガー インゲルハイム インテルナツィオナール ゲゼルシャフト ミット ベシュレンクテル ハフツング | エネルギー恒常性および細胞小器官代謝の調節に関与するMnkキナーゼ相同性タンパク質 |
US7091006B2 (en) | 2001-11-09 | 2006-08-15 | Dana-Farber Cancer Institute, Inc. | PGC-1β, a novel PGC-1 homologue and uses therefor |
CN2520883Y (zh) | 2001-12-11 | 2002-11-20 | 中国人民解放军海军潜艇学院 | 电疗仪 |
EP1476080A4 (en) | 2002-02-20 | 2010-06-02 | Medicis Technologies Corp | ULTRASOUND TREATMENT AND COMPOSITE EXPLANATION OF FAT FABRICS |
MXPA04008992A (es) | 2002-03-15 | 2005-10-18 | Gen Hospital Corp | Metodos y dispositivos para la separacion selectiva de tejido graso mediante enfriamiento controlado. |
US7239912B2 (en) | 2002-03-22 | 2007-07-03 | Leptos Biomedical, Inc. | Electric modulation of sympathetic nervous system |
US7689277B2 (en) | 2002-03-22 | 2010-03-30 | Leptos Biomedical, Inc. | Neural stimulation for treatment of metabolic syndrome and type 2 diabetes |
AU2003228603A1 (en) | 2002-04-22 | 2003-11-10 | Rtc Research And Development, Llc. | Compositions and methods for promoting weight loss, thermogenesis, appetite suppression, lean muscle mass, increasing metabolism and boosting energy levels, and use as a dietary supplement in mammals |
US20040077566A9 (en) | 2002-05-09 | 2004-04-22 | Millennium Pharmaceuticals, Inc. | Methods and compositions for the treatment and diagnosis of body weight disorders |
US6565847B1 (en) | 2002-07-03 | 2003-05-20 | Vitacost.Com, Inc. | Thermogenic weight management composition |
US7236830B2 (en) | 2002-12-10 | 2007-06-26 | Northstar Neuroscience, Inc. | Systems and methods for enhancing or optimizing neural stimulation therapy for treating symptoms of Parkinson's disease and/or other movement disorders |
US7025791B2 (en) | 2002-12-02 | 2006-04-11 | Gi Dynamics, Inc. | Bariatric sleeve |
WO2004063354A2 (en) | 2003-01-10 | 2004-07-29 | The Regents Of The University Of Michigan | Compositions and methods for characterizing and regulating wnt pathways |
US7160886B2 (en) | 2003-03-03 | 2007-01-09 | Merck & Co., Inc. | Acylated piperazine derivatives as melanocortin-4 receptor agonists |
HUE035374T2 (hu) | 2003-03-13 | 2018-05-02 | Real Aesthetics Ltd | Ultrahangos cellulitis kezelés |
AU2004226452B2 (en) | 2003-03-26 | 2008-07-24 | Merck Sharp & Dohme Corp. | Bicyclic piperidine derivatives as melanocortin-4 receptor agonists |
US7463928B2 (en) | 2003-04-25 | 2008-12-09 | Medtronic, Inc. | Identifying combinations of electrodes for neurostimulation therapy |
WO2004110175A1 (en) | 2003-06-04 | 2004-12-23 | Nestec S.A. | Weight management beverage |
JP4231349B2 (ja) | 2003-07-02 | 2009-02-25 | 株式会社ディスコ | レーザー加工方法およびレーザー加工装置 |
US20050136429A1 (en) | 2003-07-03 | 2005-06-23 | Massachusetts Institute Of Technology | SIRT1 modulation of adipogenesis and adipose function |
US7825235B2 (en) | 2003-08-18 | 2010-11-02 | Isis Pharmaceuticals, Inc. | Modulation of diacylglycerol acyltransferase 2 expression |
US20050045498A1 (en) | 2003-08-25 | 2005-03-03 | Kimberly-Clark Worldwide, Inc. | Cold pack |
US7565198B2 (en) | 2004-02-12 | 2009-07-21 | Medtronic Urinary Solutions, Inc. | Systems and methods for bilateral stimulation of left and right branches of the dorsal genital nerves to treat dysfunctions, such as urinary incontinence |
JP3951271B2 (ja) | 2003-09-30 | 2007-08-01 | 小林製薬株式会社 | 体脂肪燃焼促進剤 |
US7576052B2 (en) | 2003-10-17 | 2009-08-18 | Joslin Diabetes Center, Inc. | Methods and compositions for modulating adipocyte function |
WO2005040109A1 (en) | 2003-10-22 | 2005-05-06 | Neurocrine Biosciences, Inc. | Ligands of melanocortin receptors and compositions and methods related thereto |
US8620402B2 (en) | 2003-10-30 | 2013-12-31 | Halthion Medical Technologies, Inc. | Physiological sensor device |
KR100661118B1 (ko) | 2003-11-12 | 2006-12-26 | 주식회사 엘지생명과학 | 멜라노코틴 수용체의 항진제 |
GB0402492D0 (en) | 2004-02-04 | 2004-03-10 | Pfizer Ltd | Pharmaceutically active compounds |
AU2005212165A1 (en) | 2004-02-11 | 2005-08-25 | Ethicon, Inc. | System and method for urodynamic evaluation utilizing micro-electronic mechanical system |
US7979137B2 (en) | 2004-02-11 | 2011-07-12 | Ethicon, Inc. | System and method for nerve stimulation |
US7647112B2 (en) | 2004-02-11 | 2010-01-12 | Ethicon, Inc. | System and method for selectively stimulating different body parts |
US8165695B2 (en) | 2004-02-11 | 2012-04-24 | Ethicon, Inc. | System and method for selectively stimulating different body parts |
US8751003B2 (en) | 2004-02-11 | 2014-06-10 | Ethicon, Inc. | Conductive mesh for neurostimulation |
US7691823B2 (en) | 2004-03-05 | 2010-04-06 | University Of Massachusetts | RIP140 regulation of glucose transport |
US7476406B1 (en) | 2004-05-17 | 2009-01-13 | Nse Products, Inc. | Multifaceted weight control system |
US20060014178A1 (en) | 2004-05-26 | 2006-01-19 | Whitson Robert H | Use of Mrf-2 for screening and therapies |
HUP0401177A2 (en) | 2004-06-14 | 2007-09-28 | N Gene Res Lab Inc | Pharmaceutical composition for increasing the mitochondrial genesis |
US20050288740A1 (en) | 2004-06-24 | 2005-12-29 | Ethicon Endo-Surgery, Inc. | Low frequency transcutaneous telemetry to implanted medical device |
US7191007B2 (en) | 2004-06-24 | 2007-03-13 | Ethicon Endo-Surgery, Inc | Spatially decoupled twin secondary coils for optimizing transcutaneous energy transfer (TET) power transfer characteristics |
US7599743B2 (en) | 2004-06-24 | 2009-10-06 | Ethicon Endo-Surgery, Inc. | Low frequency transcutaneous energy transfer to implanted medical device |
US7599744B2 (en) | 2004-06-24 | 2009-10-06 | Ethicon Endo-Surgery, Inc. | Transcutaneous energy transfer primary coil with a high aspect ferrite core |
US20060008540A1 (en) | 2004-07-08 | 2006-01-12 | Rulin Xiu | Herbal compositions comprising portaluca |
AU2005275232A1 (en) | 2004-07-16 | 2006-02-23 | Merck & Co., Inc. | Acylated piperidine derivatives as melanocortin-4 receptor agonists |
ATE454148T1 (de) | 2004-07-19 | 2010-01-15 | Merck & Co Inc | Acylierte piperidinderivative als melanocortin-4- rezeptoragonisten |
US20060084637A1 (en) | 2004-10-18 | 2006-04-20 | Maria Alemany | Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same |
DE102005000666B3 (de) | 2005-01-04 | 2006-10-05 | Sanofi-Aventis Deutschland Gmbh | Sulfonylpyrrolidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
US20060204599A1 (en) | 2005-03-14 | 2006-09-14 | Wheat Jared R | Dietary supplement and method of using same |
EP1863561A4 (en) | 2005-03-15 | 2011-04-20 | Univ California | METHOD AND SYSTEM FOR MODULATING ENERGETIC EXPENDITURE AND NEUROTROPHIC FACTORS |
EA013121B1 (ru) | 2005-03-31 | 2010-02-26 | Амилин Фармасьютикалз, Инк. | Амилин и агонисты амилина для лечения психиатрических заболеваний и расстройств |
US7825098B2 (en) | 2005-04-04 | 2010-11-02 | Joslin Diabetes Center, Inc. | Methods and compositions for modulating Necdin function |
US7300409B2 (en) | 2005-05-12 | 2007-11-27 | S.C. Johnson & Son, Inc. | Therapy patch |
US8588930B2 (en) | 2005-06-07 | 2013-11-19 | Ethicon, Inc. | Piezoelectric stimulation device |
JP2008545799A (ja) | 2005-06-10 | 2008-12-18 | ボード オブ スーパーバイザーズ オブ ルイジアナ ステイト ユニバーシティー アンド アグリカルチュラル アンド メカニカル カレッジ | 脂肪組織における末梢時計の調節 |
WO2007015157A2 (en) | 2005-08-01 | 2007-02-08 | Pfizer Limited | Mc4r-ag0nists for the treatment of urinary tract dysfunction |
JP2009503050A (ja) | 2005-08-04 | 2009-01-29 | ファイザー・リミテッド | ピペリジノイル−ピロリジンおよびピペリジノイル−ピペリジン化合物 |
WO2007026347A1 (en) | 2005-09-01 | 2007-03-08 | Power Paper Ltd | Double-sided patch |
CA2558653C (en) | 2005-09-08 | 2012-12-18 | Aloka Co., Ltd. | Computerized tomography device using x rays and image processing method |
CN101277960A (zh) | 2005-09-29 | 2008-10-01 | 默克公司 | 作为黑皮质素-4受体调节剂的酰化螺哌啶衍生物 |
US20100160306A1 (en) | 2005-09-30 | 2010-06-24 | Bakshi Raman K | Acylated Piperidine Derivatives as Melanocortin-4 Receptor Agonists |
CA2625877A1 (en) | 2005-10-18 | 2007-04-26 | Merck & Co., Inc. | Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
US9061146B2 (en) | 2005-10-28 | 2015-06-23 | Medtronic, Inc. | Impedance-based bladder sensing |
US20070282318A1 (en) | 2006-05-16 | 2007-12-06 | Spooner Gregory J | Subcutaneous thermolipolysis using radiofrequency energy |
CN2899835Y (zh) | 2006-05-18 | 2007-05-16 | 陕西秦明医学仪器股份有限公司 | 植入式减肥刺激器 |
US20080262411A1 (en) | 2006-06-02 | 2008-10-23 | Dobak John D | Dynamic nerve stimulation in combination with other eating disorder treatment modalities |
US7264602B1 (en) | 2006-06-28 | 2007-09-04 | Longsworth Sheryl M | Bandage assembly |
US7623278B2 (en) | 2006-09-26 | 2009-11-24 | Xerox Corporation | MEMS Fabry-Perot inline color scanner for printing applications using stationary membranes |
CN101795627A (zh) | 2006-10-04 | 2010-08-04 | 伊西康内外科公司 | 用于腔内胃限制、组织操作和药物输送的装置和方法 |
WO2008063330A2 (en) | 2006-10-18 | 2008-05-29 | Dana-Farber Cancer Institute, Inc. | Molecular control of brown fat differentiation and energy expenditure |
US20080132962A1 (en) | 2006-12-01 | 2008-06-05 | Diubaldi Anthony | System and method for affecting gatric functions |
CA2609837A1 (en) | 2006-12-06 | 2008-06-06 | H3 Formulations Ltd. | Composition and method for supporting thermogenesis and lipid oxidation |
US8128576B2 (en) | 2006-12-07 | 2012-03-06 | Ethicon, Inc. | System and method for urodynamic evaluation utilizing micro electro-mechanical system technology |
US8175718B2 (en) | 2006-12-19 | 2012-05-08 | Ethicon, Inc. | Electrode patch and method for neurostimulation |
WO2008085290A2 (en) | 2006-12-28 | 2008-07-17 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
US20100056433A1 (en) | 2007-01-18 | 2010-03-04 | Novo Nordisk A/S | Novel Peptides for Use in the Treatment of Obesity |
WO2008087190A2 (en) | 2007-01-18 | 2008-07-24 | Novo Nordisk A/S | Use of peptides in combination with surgical intervention for the treatment of obesity |
US7815895B2 (en) | 2007-05-21 | 2010-10-19 | Tohoku University | Method for activating efferent sympathetic nerves innervating adipose tissues to improve obesity and symptoms associated therewith |
EP2170338A2 (en) | 2007-07-06 | 2010-04-07 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Dna-pkcs modulates energy regulation and brain function |
US8103355B2 (en) | 2007-07-16 | 2012-01-24 | Invasix Ltd | Method and device for minimally invasive skin and fat treatment |
US20090024144A1 (en) | 2007-07-18 | 2009-01-22 | Zeiner Mark S | Hybrid endoscopic/laparoscopic device for forming serosa to serosa plications in a gastric cavity |
US20090081715A1 (en) | 2007-09-07 | 2009-03-26 | Cobalt Technologies, Inc., A Delaware Corporation | Engineered Light-Emitting Reporter Genes |
US9529972B2 (en) | 2007-09-24 | 2016-12-27 | Medtronic, Inc. | Patient event indication |
US8352026B2 (en) | 2007-10-03 | 2013-01-08 | Ethicon, Inc. | Implantable pulse generators and methods for selective nerve stimulation |
US8162530B2 (en) | 2007-10-05 | 2012-04-24 | Main Power Electrical Factory Ltd. | Handheld electric mixer |
US8260439B2 (en) | 2007-11-16 | 2012-09-04 | Ethicon, Inc. | Nerve stimulation patches and methods for stimulating selected nerves |
WO2009067501A2 (en) | 2007-11-19 | 2009-05-28 | Joslin Diabetes Center, Inc. | Infrared thermography for monitoring brown adipose tissue |
US20090149918A1 (en) | 2007-12-06 | 2009-06-11 | Peter Krulevitch | Implantable antenna |
EP2231265A2 (en) | 2007-12-12 | 2010-09-29 | Cardiac Pacemakers, Inc. | System for delivering neurostimulation from pulmonary artery |
US8142452B2 (en) | 2007-12-27 | 2012-03-27 | Ethicon Endo-Surgery, Inc. | Controlling pressure in adjustable restriction devices |
WO2009097542A2 (en) | 2008-01-30 | 2009-08-06 | Board Of Regents Of The University Of Texas System | Ileal electrical stimulation |
US8114345B2 (en) | 2008-02-08 | 2012-02-14 | Ethicon Endo-Surgery, Inc. | System and method of sterilizing an implantable medical device |
US8057492B2 (en) | 2008-02-12 | 2011-11-15 | Ethicon Endo-Surgery, Inc. | Automatically adjusting band system with MEMS pump |
CA2718708A1 (en) | 2008-03-17 | 2009-09-24 | Geisinger Clinic | Genetic indicators of weight loss |
EP2334374A4 (en) | 2008-08-26 | 2011-12-28 | Janssen Biotech Inc | STIMULATING THE RELEASE OF A SATIETY HORMONE |
US7818060B2 (en) | 2008-10-31 | 2010-10-19 | Medtronic, Inc. | Determination of stimulation output capabilities throughout power source voltage range |
US8897885B2 (en) | 2008-12-19 | 2014-11-25 | Ethicon, Inc. | Optimizing the stimulus current in a surface based stimulation device |
US7970478B2 (en) | 2008-12-19 | 2011-06-28 | Ethicon, Inc. | Optimizing stimulation therapy of an external stimulating device based on firing of action potential in target nerve |
US8303982B2 (en) | 2009-03-20 | 2012-11-06 | Ethicon, Inc | Self-locating, multiple application, and multiple location medical patch systems and methods therefor |
US8340772B2 (en) | 2009-05-08 | 2012-12-25 | Advanced Neuromodulation Systems, Inc. | Brown adipose tissue utilization through neuromodulation |
US20110000270A1 (en) | 2009-06-18 | 2011-01-06 | Organic Green Solutions, Inc. | Organic slurry compositions and method of application |
US8126530B2 (en) | 2009-10-26 | 2012-02-28 | Ethicon, Inc. | Offset electrode |
US20110144490A1 (en) | 2009-12-10 | 2011-06-16 | General Electric Company | Devices and methods for adipose tissue reduction and skin contour irregularity smoothing |
US9220885B2 (en) | 2009-12-18 | 2015-12-29 | Ethicon, Inc. | Placement devices that enable patients to accurately position medical patches at target locations and methods therefor |
US8476227B2 (en) | 2010-01-22 | 2013-07-02 | Ethicon Endo-Surgery, Inc. | Methods of activating a melanocortin-4 receptor pathway in obese subjects |
US20120165792A1 (en) | 2010-12-22 | 2012-06-28 | Ethicon Endo-Surgery, Inc. | Pill Catchers |
US20120172783A1 (en) | 2010-12-29 | 2012-07-05 | Ethicon Endo-Surgery, Inc. | Obesity therapy and heart rate variability |
US8696616B2 (en) | 2010-12-29 | 2014-04-15 | Ethicon Endo-Surgery, Inc. | Obesity therapy and heart rate variability |
US9381219B2 (en) | 2010-12-29 | 2016-07-05 | Ethicon Endo-Surgery, Inc. | Brown adipocyte modification |
WO2012092056A1 (en) | 2010-12-29 | 2012-07-05 | Ethicon Endo-Surgery, Inc. | Methods and devices for activating brown adipose tissue with targeted substance delivery |
US10441459B2 (en) | 2010-12-29 | 2019-10-15 | Ethicon Endo-Surgery, Inc. | Methods and devices for activating brown adipose tissue with cooling |
FR2972942B1 (fr) | 2011-03-21 | 2017-11-24 | Arkema France | Procede de fabrication de nanotubes de carbone et appareil pour la mise en oeuvre du procede. |
US9314609B2 (en) | 2011-10-28 | 2016-04-19 | Martin Brown | Device for providing electrical stimulation of a human knee |
US20130209418A1 (en) * | 2012-02-15 | 2013-08-15 | Johnson & Johnson Regenerative Therapeutics, Llc | Methods and composition related to brown adipose-like cells |
US8812100B2 (en) | 2012-05-10 | 2014-08-19 | Ethicon Endo-Surgery, Inc. | Device and method for self-positioning of a stimulation device to activate brown adipose tissue depot in a supraclavicular fossa region |
US10092738B2 (en) | 2014-12-29 | 2018-10-09 | Ethicon Llc | Methods and devices for inhibiting nerves when activating brown adipose tissue |
-
2014
- 2014-12-29 US US14/584,046 patent/US10092738B2/en active Active
-
2015
- 2015-12-14 EP EP15828707.8A patent/EP3240606B1/en active Active
- 2015-12-14 JP JP2017553044A patent/JP6668379B2/ja active Active
- 2015-12-14 BR BR112017013892-1A patent/BR112017013892B1/pt active IP Right Grant
- 2015-12-14 CN CN201580077109.8A patent/CN107278161B/zh active Active
- 2015-12-14 WO PCT/US2015/065513 patent/WO2016109169A1/en active Application Filing
-
2018
- 2018-08-22 US US16/108,132 patent/US10960201B2/en active Active
-
2021
- 2021-03-17 US US17/203,904 patent/US20210205608A1/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030018367A1 (en) * | 2001-07-23 | 2003-01-23 | Dilorenzo Daniel John | Method and apparatus for neuromodulation and phsyiologic modulation for the treatment of metabolic and neuropsychiatric disease |
JP2011505981A (ja) * | 2007-12-14 | 2011-03-03 | エシコン・インコーポレイテッド | デルマトーム刺激の装置及び方法 |
JP2013517835A (ja) * | 2010-01-22 | 2013-05-20 | エシコン・エンド−サージェリィ・インコーポレイテッド | 電気エネルギーを用いて褐色脂肪組織を活性化する方法および装置 |
US20140088487A1 (en) * | 2010-12-29 | 2014-03-27 | Ethicon Endo-Surgery, Inc. | Methods and devices for activating brown adipose tissue with light |
US20120290023A1 (en) * | 2011-05-09 | 2012-11-15 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Method, device and system for modulating an activity of brown adipose tissue in a vertebrate subject |
JP2013126486A (ja) * | 2011-12-19 | 2013-06-27 | Panasonic Corp | 電気刺激装置 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2021516098A (ja) * | 2018-03-09 | 2021-07-01 | ゼネラル・エレクトリック・カンパニイ | ニューロモジュレーション技術 |
US11938348B2 (en) | 2018-03-09 | 2024-03-26 | General Electric Company | Neuromodulation techniques |
Also Published As
Publication number | Publication date |
---|---|
US20160184568A1 (en) | 2016-06-30 |
US20210205608A1 (en) | 2021-07-08 |
BR112017013892A2 (pt) | 2018-01-02 |
EP3240606B1 (en) | 2022-11-16 |
US10092738B2 (en) | 2018-10-09 |
WO2016109169A1 (en) | 2016-07-07 |
JP6668379B2 (ja) | 2020-03-18 |
US10960201B2 (en) | 2021-03-30 |
CN107278161A (zh) | 2017-10-20 |
US20180369549A1 (en) | 2018-12-27 |
BR112017013892B1 (pt) | 2022-11-08 |
EP3240606A1 (en) | 2017-11-08 |
CN107278161B (zh) | 2021-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210205608A1 (en) | Methods and devices for inhibiting nerves when activating brown adipose tissue | |
US10080899B2 (en) | Systems and methods for treating autonomic instability and medical conditions associated therewith | |
US9662486B2 (en) | Methods and devices for activating brown adipose tissue using electrical energy | |
US7702386B2 (en) | Nerve stimulation for treatment of obesity, metabolic syndrome, and Type 2 diabetes | |
US8340772B2 (en) | Brown adipose tissue utilization through neuromodulation | |
EP3527257A2 (en) | Neuromodulatory systems and methods for treating functional gastrointestinal disorders | |
US20100234907A1 (en) | Splanchnic Nerve Stimulation for Treatment of Obesity | |
US9364668B2 (en) | Apparatus, systems, and methods for treating body organ aging | |
EP1984067A2 (en) | Nerve stimulation for treatment of obesity, type 2 diabetes, and metabolic syndrome | |
US11679252B2 (en) | Methods and devices for activating brown adipose tissue using electrical energy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20181011 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20191001 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20191204 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200218 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200226 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6668379 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |